MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.phymed.2022.154158

Медицинская библиотека · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2022

Natural medicine HLXL targets multiple pathways of amyloid-mediated neuroinflammation and immune response in treating alzheimer's disease.

Liang Yingxia, Lee David Y W, Zhen Sherri, Sun Haoqi, Zhu Biyue, Liu Jing, Lei Dan, Lin Chih-Chung Jerry, Zhang Siyi, Jacques Nicholas A, Quinti Luisa, Ran Chongzhao, Wang Changning, Griciuc Ana, Choi Se Hoon, Dai Rong Hua, Efferth Thomas, Tanzi Rudolph E, Zhang Can

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Based on the complex pathology of AD, a single chemical approach may not be sufficient to deal simultaneously with multiple pathways of amyloid-tau neuroinflammation. A polydrug approach which contains multiple bioactive components targeting multiple pathways in AD would be more appropriate. Here we focused on a Chinese medicine (HLXL), which contains 56 bioactive natural products identified in 11 medicinal plants and displays potent anti-inflammatory and immuno-modulatory activity.

HYPOTHESIS/PURPOSE: We investigated the neuroimmune and neuroinflammation mechanisms by which HLXL may attenuate AD neuropathology. Specifically, we investigated the effects of HLXL on the neuropathology of AD using both transgenic mouse models as well as microglial cell-based models.

STUDY

DESIGN

The 5XFAD transgenic animals and microglial cell models were respectively treated with HLXL and Aβ42, and/or lipopolysaccharide (LPS), and then analyzed focusing on microglia mediated Aβ uptake and clearance, as well as pathway changes.

METHODS

We showed that HLXL significantly reduced amyloid neuropathology by upregulation of microglia-mediated phagocytosis of Aβ both in vivo and in vitro. HLXL displayed multi-modal mechanisms regulating pathways of phagocytosis and energy metabolism.

RESULTS

Our results may not only open a new avenue to support pharmacologic modulation of neuroinflammation and the neuroimmune system for AD intervention, but also identify HLXL as a promising natural medicine for AD.

CONCLUSION

It is conceivable that the traditional wisdom of natural medicine in combination with modern science and technology would be the best strategy in developing effective therapeutics for AD.

Для цитирования: Liang Yingxia, Lee David Y W, Zhen Sherri, Sun Haoqi, Zhu Biyue, Liu Jing, Lei Dan, Lin Chih-Chung Jerry, Zhang Siyi, Jacques Nicholas A, Quinti Luisa, Ran Chongzhao, Wang Changning, Griciuc Ana, Choi Se Hoon, Dai Rong Hua, Efferth Thomas, Tanzi Rudolph E, Zhang Can. Natural medicine HLXL targets multiple pathways of amyloid-mediated neuroinflammation and immune response in treating alzheimer's disease.. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2022. DOI: 10.1016/j.phymed.2022.154158.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.